The role of transforming growth factor-ß (TGF-ß1) in postmenopausal women with pelvic organ prolapse: An immunohistochemical study.
Immunohistochemistry
Pelvic organ prolapse
Postmenopausal women
TGF-ß1 expression
Uterosacral ligament
Journal
European journal of obstetrics & gynecology and reproductive biology: X
ISSN: 2590-1613
Titre abrégé: Eur J Obstet Gynecol Reprod Biol X
Pays: Netherlands
ID NLM: 101750520
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
05
03
2020
revised:
28
04
2020
accepted:
02
05
2020
entrez:
28
7
2020
pubmed:
28
7
2020
medline:
28
7
2020
Statut:
epublish
Résumé
Aim of the study was to investigate the expression of transforming growth factor-β1 (TGF-β1), a key regulator of the extracellular matrix composition, in the uterosacral ligaments (USLs) of women with pelvic organ prolapse (POP) compared with controls. We hypothesized that the expression pattern of TGF-β1 differs between postmenopausal women with or without POP. Under ethical approval, USL samples were obtained from postmenopausal women undergoing vaginal hysterectomy for stage two or greater pelvic organ prolapse (cases, n = 70) and from postmenopausal women without pelvic organ prolapse undergoing vaginal hysterectomy for benign indications (controls, n = 30). Immunohistochemical staining was performed from paraffin embedded tissue using anti-TGF-β1 antibodies. The expression of TGF-β1 was evaluated by the pathologist, who was blinded to all clinical data. The expression of TGF-ß1 was similar in patients with symptomatic POP (89 % positive) and in controls (90 % positive) without any signs of prolapse (p = 0.091). Age-adjusted analysis did not significantly alter these results. Regarding POP-Q stages, TGF-ß1 was significantly more frequently expressed in severe prolapse cases compared to moderate/mild cases (POP-Q stage IV versus POP-Q stage II and III; p = 0.001). No significant association could be detected between TGF-ß1 expression and age, BMI and parity in cases with POP (p > 0.05). As published previously, advanced patients' age as well as early menopausal age remained independent risk factors associated with POP in multiple logistic regression analysis (p = 0.001; p = 0.02). Although our study detected POP-Q stage related alterations in USL composition and TGF-ß1 expression, there was no significant difference in the expression of TGF-β1 in cases with or without prolapse.
Identifiants
pubmed: 32715292
doi: 10.1016/j.eurox.2020.100111
pii: S2590-1613(20)30005-3
pii: 100111
pmc: PMC7379135
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100111Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Clin Endocrinol Metab. 2014 Oct;99(10):3728-36
pubmed: 24947034
Mol Med Rep. 2017 May;15(5):3278-3284
pubmed: 28339064
Obstet Gynecol. 2014 Jan;123(1):141-8
pubmed: 24463674
Female Pelvic Med Reconstr Surg. 2015 Jan-Feb;21(1):53-8
pubmed: 25185601
Am J Obstet Gynecol. 2002 Apr;186(4):712-6
pubmed: 11967496
Am J Obstet Gynecol. 2005 Mar;192(3):795-806
pubmed: 15746674
Saudi Med J. 2011 May;32(5):474-8
pubmed: 21556467
Eur J Clin Invest. 2007 Jun;37(6):516-21
pubmed: 17537160
Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:185-189
pubmed: 30710765
Urology. 2003 Jan;61(1):37-49
pubmed: 12559262
Clin Exp Obstet Gynecol. 2013;40(4):586-90
pubmed: 24597264
Hum Reprod. 2006 May;21(5):1266-73
pubmed: 16452154
Gynecol Surg. 2017;14(1):3
pubmed: 28458627
Int Urogynecol J. 2014 Apr;25(4):441-3
pubmed: 24504065
Acta Obstet Gynecol Scand. 2004 Dec;83(12):1193-8
pubmed: 15548155
Obstet Gynecol. 1997 Apr;89(4):501-6
pubmed: 9083302
Lancet. 1996 Jun 15;347(9016):1658-61
pubmed: 8642960
Int Urogynecol J Pelvic Floor Dysfunct. 2009 Apr;20(4):461-74
pubmed: 18854909
Int Urogynecol J. 2015 Nov;26(11):1559-73
pubmed: 25966804
Am J Obstet Gynecol. 2001 Jun;184(7):1496-501; discussion 1501-3
pubmed: 11408873
Mucosal Immunol. 2009 Mar;2(2):103-21
pubmed: 19129758
Am J Obstet Gynecol. 1996 Jul;175(1):10-7
pubmed: 8694033
Taiwan J Obstet Gynecol. 2016 Feb;55(1):9-15
pubmed: 26927240
BJOG. 2006 Jan;113(1):39-46
pubmed: 16398770
Int Urogynecol J Pelvic Floor Dysfunct. 2005 Nov-Dec;16(6):475-9
pubmed: 15846454
Int Urogynecol J Pelvic Floor Dysfunct. 2003 Jun;14(2):122-7
pubmed: 12851756
Int Urogynecol J. 2013 Dec;24(12):2011-20
pubmed: 23649687
Am J Obstet Gynecol. 2003 Jul;189(1):89-97
pubmed: 12861144
Int Urogynecol J. 2013 Oct;24(10):1645-50
pubmed: 23536227
Am J Obstet Gynecol. 2001 Dec;185(6):1332-7; discussion 1337-8
pubmed: 11744905
Gynecol Obstet Invest. 2013;75(1):21-7
pubmed: 23108059
Int Urogynecol J. 2012 Apr;23(4):495-500
pubmed: 22124513